- Investing Ideas
- /
- Global Pharmaceuticals & Biotech Undervalued over 20% based on DCF
Global Pharmaceuticals & Biotech Undervalued over 20% based on DCF
Results
159
Companies which are undervalued more than 20% based on the Discounted Cash Flow valuation.
159 companies
Eli Lilly
Market Cap: US$687.6b
Eli Lilly and Company discovers, develops, and markets human pharmaceuticals in the United States, Europe, China, Japan, and internationally.
LLY
US$746.37
7D
-1.8%
1Y
-3.3%
Johnson & Johnson
Market Cap: US$411.2b
Engages in the research and development, manufacture, and sale of various products in the healthcare field worldwide.
JNJ
US$170.59
7D
2.0%
1Y
7.4%
Thermo Fisher Scientific
Market Cap: US$176.1b
Provides life sciences solutions, analytical instruments, specialty diagnostics, and laboratory products and biopharma services in the North America, Europe, Asia-Pacific, and internationally.
TMO
US$448.94
7D
-5.9%
1Y
-23.6%
Danaher
Market Cap: US$142.5b
Designs, manufactures, and markets professional, medical, research, and industrial products and services in the United States, China, and internationally.
DHR
US$195.17
7D
-4.3%
1Y
-25.9%
CSL
Market Cap: AU$130.5b
Researches, develops, manufactures, markets, and distributes biopharmaceutical and vaccines in Australia, the United States, Germany, the United Kingdom, Switzerland, China, Hong Kong, and internationally.
CSL
AU$269.60
7D
-0.6%
1Y
-11.4%
Zoetis
Market Cap: US$64.8b
Engages in the discovery, development, manufacture, and commercialization of animal health medicines, vaccines, diagnostic products and services, biodevices, genetic tests, and precision animal health products in the United States and internationally.
ZTS
US$146.50
7D
-1.6%
1Y
-20.7%
Samsung BiologicsLtd
Market Cap: ₩73.4t
Together with its subsidiaries engages in the manufacturing of biopharmaceuticals products in South Korea, Europe, the United States, and internationally.
A207940
₩1,031,000.00
7D
-6.1%
1Y
7.4%
Daiichi Sankyo Company
Market Cap: JP¥6.8t
Manufactures and sells pharmaceutical products in Japan, North America, Europe, and internationally.
4568
JP¥3,658.00
7D
0.1%
1Y
-34.7%
Haleon
Market Cap: UK£31.3b
Engages in the research, development, manufacture, and sale of various consumer healthcare products in North America, Europe, the Middle East, Africa, Latin America, and the Asia Pacific.
HLN
UK£3.48
7D
-4.6%
1Y
-6.9%
Galderma Group
Market Cap: CHF 30.2b
Operates as a dermatology company worldwide.
GALD
CHF 127.30
7D
-2.1%
1Y
79.3%
WuXi AppTec
Market Cap: CN¥267.1b
An investment holding company, provides research and manufacturing services to discover, develop, and manufacture spectrum for small molecule drugs in the People’s Republic of China, the United States, Europe, and internationally.
603259
CN¥93.58
7D
-5.3%
1Y
118.1%
BeOne Medicines
Market Cap: US$36.5b
An oncology company, engages in discovering and developing various treatments for cancer patients in the United States, China, Europe, and internationally.
ONC
US$298.52
7D
-0.5%
1Y
68.9%
IQVIA Holdings
Market Cap: US$31.3b
Provides clinical research services, commercial insights, and healthcare intelligence to the life sciences and healthcare industries in the Americas, Europe, Africa, and the Asia-Pacific.
IQV
US$177.49
7D
-7.3%
1Y
-22.7%
Sartorius Stedim Biotech
Market Cap: €16.5b
Engages in the production and sale of instruments and consumables for the biopharmaceutical industry worldwide.
DIM
€165.55
7D
-6.9%
1Y
-6.0%
Natera
Market Cap: US$19.1b
A diagnostics company, provides molecular testing services worldwide.
NTRA
US$138.13
7D
-2.0%
1Y
37.6%
Sino Biopharmaceutical
Market Cap: HK$134.1b
An investment holding company, operates as a research and development pharmaceutical conglomerate in the People’s Republic of China.
1177
HK$7.50
7D
-0.3%
1Y
163.2%
Waters
Market Cap: US$16.7b
Provides analytical workflow solutions in Asia, the Americas, and Europe.
WAT
US$277.72
7D
-7.1%
1Y
-13.7%
WuXi Biologics (Cayman)
Market Cap: HK$128.7b
An investment holding company, provides end-to-end solutions and services for biologics discovery, development, and manufacturing for biologics industry in the People’s Republic of China, North America, Europe, Singapore, Japan, South Korea, and Australia.
2269
HK$31.62
7D
-5.3%
1Y
181.3%
Incyte
Market Cap: US$15.2b
A biopharmaceutical company, engages in the discovery, development, and commercialization of therapeutics in the United States, Europe, Canada, and Japan.
INCY
US$77.65
7D
0.1%
1Y
28.8%
Shionogi
Market Cap: JP¥2.2t
Engages in the research, development, manufacture, and distribution of pharmaceuticals, diagnostic reagents, and medical devices in Japan.
4507
JP¥2,627.00
7D
3.9%
1Y
25.7%
CSPC Pharmaceutical Group
Market Cap: HK$115.0b
An investment holding company, engages in the manufacture and sale of pharmaceutical products in Mainland China, other Asian regions, Europe, North America, and internationally.
1093
HK$10.06
7D
-0.4%
1Y
69.9%
Yunnan Baiyao GroupLtd
Market Cap: CN¥99.8b
Engages in the pharmaceutical business in China, Southeast Asia, Europe, the United States, Japan, and internationally.
000538
CN¥55.96
7D
-2.5%
1Y
9.4%
Eurofins Scientific
Market Cap: €11.5b
Provides various analytical testing and laboratory services worldwide.
ERF
€64.60
7D
-2.2%
1Y
22.4%
ICON
Market Cap: US$12.9b
A clinical research organization, provides outsourced development and commercialization services in Ireland, rest of Europe, the United States, and internationally.
ICLR
US$155.42
7D
-14.4%
1Y
-49.3%
Medpace Holdings
Market Cap: US$12.3b
Provides clinical research-based drug and medical device development services in North America, Europe, and Asia.
MEDP
US$430.37
7D
-1.7%
1Y
17.0%
Sichuan Kelun-Biotech Biopharmaceutical
Market Cap: HK$95.9b
A biopharmaceutical company, engages in the research and development, manufacturing, and commercialization of novel drugs in oncology, immunology, and other therapeutic areas in the People’s Republic of China and internationally.
6990
HK$419.80
7D
8.0%
1Y
164.5%
Recordati Industria Chimica e Farmaceutica
Market Cap: €10.4b
Researches, develops, produces, and sells pharmaceuticals in Italy, the United States, Spain, France, Germany, Russia, Ukraine, Turkey, Portugal, North Africa, and internationally.
REC
€50.25
7D
-3.3%
1Y
1.6%
Qiagen
Market Cap: US$10.8b
Provides sample to insight solutions that transform biological samples into molecular insights in the Netherlands and internationally.
QGEN
US$47.49
7D
-6.1%
1Y
3.9%
Orion Oyj
Market Cap: €9.3b
Develops, manufactures, and markets human and veterinary pharmaceuticals and active pharmaceutical ingredients (APIs) in Finland, Scandinavia, rest of Europe, North America, and internationally.
ORNBV
€66.00
7D
-6.8%
1Y
53.2%
Revvity
Market Cap: US$10.5b
Provides health sciences solutions, technologies, and services worldwide.
RVTY
US$85.90
7D
-5.4%
1Y
-25.7%
Ipsen
Market Cap: €8.7b
Operates as a biopharmaceutical company worldwide.
IPN
€105.30
7D
-5.8%
1Y
2.7%
Grifols
Market Cap: €7.8b
Operates as a plasma therapeutic company in Spain, the United States, Canada, and internationally.
GRF
€12.81
7D
-5.2%
1Y
43.2%
Caris Life Sciences
Market Cap: US$8.4b
An artificial intelligence TechBio company, provides molecular profiling services in the United States and internationally.
CAI
US$28.95
7D
-1.9%
1Y
n/a
Charles River Laboratories International
Market Cap: US$8.2b
Charles River Laboratories International, Inc.
CRL
US$150.33
7D
-14.7%
1Y
-24.8%
Eisai
Market Cap: JP¥1.2t
Engages in the research and development, manufacture, sale, and import and export of pharmaceuticals in Japan.
4523
JP¥4,249.00
7D
1.2%
1Y
-23.3%
Imeik Technology DevelopmentLtd
Market Cap: CN¥55.4b
Engages in the research and development, production, and transformation of biomedical soft tissue repair materials in China.
300896
CN¥183.89
7D
-3.0%
1Y
6.9%